The effect of therapeutic and supratherapeutic oral doses of nomegestrol acetate (NOMAC)/17β-estradiol (E2) on QTcF intervals in healthy women: results from a randomized, double-blind, placebo- and positive-controlled trial.

First published in Clinical Drug Investigation on 2014 Jun.
Clin Drug Investig. 2014 Jun;34(6):413-20. doi: 10.1007/s40261-014-0190-5.

Authors: de Kam PJ, van Kuijk J, Lillin O, Post T, Thomsen T

 

 

 

 

Read more

Download full article as Pdf file:

Pdf File

 

REACHING OUT IS EASY AND FAST – LET’S TALK

Prof. Dr. Thomas Forst

Chairman of the Executive Board
located at CRS Mannheim


LET’S TALK SCIENCE
Dr. Marc Hetzel

VP & Head of Business Development
located at CRS Management


LET’S TALK BUSINESS